Gil Lavie

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

Ronen Arbel, Yael Wolff Sagy, Moshe Hoshen et al. · New England Journal of Medicine · 2022 · 367 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Real-world effectiveness of a single dose of mpox vaccine in males

Yael Wolff Sagy, Roy Zucker, Ariel Hammerman et al. · Nature Medicine · 2023 · 202 citations · Full text

Veterinary Medicine, Immunology, Preventive Medicine +14

Smoking and the risk of COVID-19 in a large observational population study

Ariel Israel, Elan Feldhamer, Amnon Lahad et al. · medRxiv · 2020 · 70 citations · Full text

Public Health, Health Sciences, Infectious Diseases +13

Estimating the economic burden of long-Covid: the additive cost of healthcare utilisation among COVID-19 recoverees in Israel

Yael Wolff Sagy, Ilan Feldhamer, Shuli Brammli‐Greenberg et al. · BMJ Global Health · 2023 · 68 citations · Full text

Social Sciences, Pharmacoeconomics, Health Economics +16

Identification of drugs associated with reduced severity of COVID-19 – a case-control study in a large population

Ariel Israel, Alejandro A. Schäffer, Assi Cicurel et al. · eLife · 2021 · 54 citations · Full text

Public Affairs, Infectious Disease Control, Pharmacotherapy +13